Literature DB >> 19806053

Virtual neck exploration: a new method for localizing abnormal parathyroid glands.

Rupert Prommegger1, Gerd Wimmer, Christoph Profanter, Tonja Sauper, Michael Sieb, Peter Kovacs, Reto Bale, Daniel Putzer, Michael Gabriel, Raimund Margreiter.   

Abstract

BACKGROUND DATA: Computed tomography (CT) together with 99mTc-sestamibi single photon emission computed tomography (MIBI-SPECT) image fusion (CT-MIBI-SPECT image fusion) allows virtual exploration of the neck. The aim of this study was to evaluate whether CT-MIBI-SPECT image fusion is superior to MIBI-SPECT and CT in detecting abnormal parathyroid glands in patients with primary hyperparathyroidism.
METHODS: CT-MIBI-SPECT image fusion for preoperative localization was performed in 116 patients with primary hyperparathyroidism (pHPT). Both investigations were performed with reproducible fixation of the patient on a vacuum mattress. At a special work station the neck was virtually explored by viewing the CT images in all 3 dimensions. The MIBI-SPECT images were superimposed on underlying CT images. Only patients with single-gland disease were evaluated (pHPT: 112, persistent pHPT: 1, recurrent pHPT: 1, persistent secondary hyperparathyroidism: 1, tertiary HPT after kidney transplantation: 1). CT-MIBI-SPECT image fusion results were compared with those obtained with CT alone and MIBI-SPECT alone. The predicted positions were correlated with the intraoperative findings.
RESULTS: CT-MIBI-SPECT image fusion was able to predict the exact position of the abnormal gland in 102 (88%) of the 116 patients, whereas CT alone showed in 75 (65%) patients and MIBI-SPECT alone in 64 (55%) patients the exact position of the abnormal gland. Sixty-two patients underwent minimally invasive surgery, namely in 21 patients with a unilaterally focused approach and in 33 patients with a bilateral approach (27 of these underwent simultaneous thyroid resection). Sensitivity for CT-MIBI-SPECT image fusion was 88%, for CT alone 70%, and for MIBI-SPECT alone 59%. Specificity for CT-MIBI-SPECT image fusion was 99%, for MIBI-SPECT alone 95%, for CT alone 94%. Overall accuracy for CT-MIBI-SPECT image fusion was 97%, for CT alone 89%, for MIBI-SPECT 87%.
CONCLUSIONS: This study provides evidence that CT-MIBI-SPECT image fusion is superior to CT or MIBI-SPECT alone for preoperative localization of enlarged parathyroid glands in patients with single-gland primary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19806053     DOI: 10.1097/SLA.0b013e3181bd906b

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  13 in total

Review 1.  Clinical aspects of primary hyperparathyroidism: clinical manifestations, diagnosis, and therapy.

Authors:  Rudolf Wolfgang Gasser
Journal:  Wien Med Wochenschr       Date:  2013-08-29

2.  Super-selective venous sampling in conjunction with quickPTH for patients with persistent primary hyperparathyroidism: report of five cases.

Authors:  Oliver Gimm; Lars-Gunnar Arnesson; Pia Olofsson; Olallo Morales; Claes Juhlin
Journal:  Surg Today       Date:  2012-01-26       Impact factor: 2.549

3.  Endocrine radionuclide scintigraphy with fusion single photon emission computed tomography/computed tomography.

Authors:  Ka-Kit Wong; Arpit Gandhi; Benjamin L Viglianti; Lorraine M Fig; Domenico Rubello; Milton D Gross
Journal:  World J Radiol       Date:  2016-06-28

4.  Effect of reconstruction algorithms on the accuracy of (99m)Tc sestamibi SPECT/CT parathyroid imaging.

Authors:  Kenneth J Nichols; Gene G Tronco; Christopher J Palestro
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-01-15

Review 5.  [Localization of parathyroid adenomas with C11-methionine PET-CT].

Authors:  T Weber; M Luster
Journal:  Chirurg       Date:  2014-07       Impact factor: 0.955

6.  Primary hyperparathyroidism: an analysis of failure of parathyroidectomy.

Authors:  A Bagul; H P Patel; D Chadwick; B J Harrison; S P Balasubramanian
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

7.  Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK).

Authors:  T Weber; C Dotzenrath; H Dralle; B Niederle; P Riss; K Holzer; J Kußmann; A Trupka; T Negele; R Kaderli; E Karakas; F Weber; N Rayes; A Zielke; M Hermann; C Wicke; R Ladurner; C Vorländer; J Waldmann; O Heizmann; S Wächter; S Schopf; W Timmermann; D K Bartsch; R Schmidmaier; M Luster; K W Schmid; M Ketteler; C Dierks; P Schabram; T Steinmüller; K Lorenz
Journal:  Langenbecks Arch Surg       Date:  2021-04-21       Impact factor: 3.445

Review 8.  Diagnosis and management of parathyroid cancer.

Authors:  Klaus-Martin Schulte; Nadia Talat
Journal:  Nat Rev Endocrinol       Date:  2012-07-03       Impact factor: 43.330

9.  Selective Parathyroid Hormone Venous Sampling in Patients with Persistent or Recurrent Primary Hyperparathyroidism and Negative, Equivocal or Discordant Noninvasive Imaging.

Authors:  Philip Y Sun; Scott M Thompson; James C Andrews; Robert A Wermers; Travis J McKenzie; Melanie L Richards; David R Farley; Geoffrey B Thompson
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

10.  Comparison of five parathyroid scintigraphic protocols.

Authors:  Virpi Tunninen; Pekka Varjo; Jukka Schildt; Aapo Ahonen; Tomi Kauppinen; Irina Lisinen; Anu Holm; Hannu Eskola; Marko Seppänen
Journal:  Int J Mol Imaging       Date:  2013-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.